<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Kuonen, François</dc:creator>
  <dc:creator>Laurent, Julien</dc:creator>
  <dc:creator>Secondini, Chiara</dc:creator>
  <dc:creator>Lorusso, Girieca</dc:creator>
  <dc:creator>Stehle, Jean-Christophe</dc:creator>
  <dc:creator>Rausch, Thierry</dc:creator>
  <dc:creator>Hull, Eveline Faes-van't</dc:creator>
  <dc:creator>Bieler, Gregory</dc:creator>
  <dc:creator>Alghisi, Gian Carlo</dc:creator>
  <dc:creator>Schwendener, Reto A.</dc:creator>
  <dc:creator>Andrejevic-Blant, Snezana</dc:creator>
  <dc:creator>Mirimanoff, René-Olivier</dc:creator>
  <dc:creator>Rüegg, Curzio</dc:creator>
  <dc:date>2012-06-08</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Purpose: Local breast cancer relapse after breast-saving surgery and radiotherapy is  associated with increased risk of distant metastasis formation. The mechanisms  involved remain largely elusive. We used the well-characterized 4T1 syngeneic,  orthotopic breast cancer model to identify novel mechanisms of post-radiation  metastasis. Experimental Design: 4T1 cells were injected in 20 Gy pre-irradiated  mammary tissue, to mimic post-radiation relapses, or in non-irradiated mammary  tissue, as control, of immunocompetent BALB/c mice. Molecular, biochemical, cellular,  histological analyses, adoptive cell transfer, genetic and pharmacological interventions  were performed. Results: Tumors growing in pre-irradiated mammary tissue had  reduced angiogenesis, were more hypoxic, invasive and metastatic to lung and lymph  nodes compared to control tumors. Increased metastasis involved the mobilization of  CD11b+c-Kit+Ly6GhighLy6Clow(Gr1+) myeloid cells through the HIF1-dependent  expression of KitL by hypoxic tumor cells. KitL-mobilized myeloid cells homed to  primary tumors and pre-metastatic lungs, to give rise to CD11b+c-Kit- cells.  Pharmacological inhibition of HIF1, silencing of KitL expression in tumor cells and  inhibition of c-Kit with an anti-c-Kit blocking antibody or with a tyrosine kinase inhibitor,  prevented the mobilization of CD11b+c-Kit+ cells and attenuated metastasis. C-Kit  inhibition was also effective in reducing mobilization of CD11b+c-Kit+ cells and  inhibiting lung metastasis after irradiation of established tumors. Conclusions: Our  work defines KitL/c-Kit as a previously unidentified axis critically involved in promoting  metastasis of 4T1 tumors growing in pre-irradiated mammary tissue. Pharmacological  inhibition of this axis represents a potential therapeutic strategy to prevent metastasis  in breast cancer patients with local relapses after radiotherapy.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/302449</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/302449/files/rue_ikl.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1158/1078-0432.ccr-11-3028</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Clinical Cancer Research. - 2012, vol. 18, no. 16, p. 4365-4374</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
